Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA6 | P23280 | 1/20 | 0.53 |
| ▸ | SNCA | P37840 | 2/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651451 | 0.81 | AKR1B1 (0.49) | CYP2C19CYP3A4ALOX5 | |
| SCHEMBL7915037 | 0.80 | MAPK1 (0.65) | CYP2C19CYP1A2CYP2C9ALOX5 | |
| SCHEMBL31509450 | 0.80 | MAPK1 (0.65) | CYP2C19CYP1A2CYP2C9ALOX5 | |
| SCHEMBL8963452 | 0.80 | KEAP1 (0.60) | CYP2C19CYP3A4 | |
| SCHEMBL28651474 | 0.80 | MAPT (0.64) | IDH1MAPTCA1CA2CA4 | |
| SCHEMBL2536660 | 0.78 | CYP2C19 (0.50) | IDH1CETPCYP2C19CYP1A2CYP2C9 | |
| SCHEMBL8898655 | 0.77 | MAPT (0.60) | IDH1MAPTCA1CA2CA4 | |
| SCHEMBL2512174 | 0.76 | CETP (0.49) | MAPTCETPCYP2C19CYP1A2CYP2C9 | |
| SCHEMBL31145030 | 0.76 | HSPA5 (0.67) | CETPCYP2C19CYP1A2CYP2C9HSD17B10 | |
| SCHEMBL8963436 | 0.76 | HSPA5 (0.67) | CETPCYP2C19CYP1A2CYP2C9HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4590301-A | USING PHENOL OR DIKETONE CYCLOHEXYL COMPOUNDS | BARNES-HIND, INC. (US) | 1986-05-20 | — | — | US | claimed |
| EP-0179476-A1 | Polymerization inhibitors and polymerization-inhibited solutions of monomers | Barnes-Hind, Inc. (US) | 1986-04-30 | — | — | EP | claimed |
| US-8470932-B2 | Scalable process for synthesis of a curable wax | XEROX CORPORATION (US) | 2013-06-25 | — | — | US | disclosed |
| US-8207274-B2 | Solvent-free process for synthesis of a curable wax | XEROX CORPORATION (US) | 2012-06-26 | — | — | US | disclosed |
| US-20110247521-A1 | SCALEABLE PROCESS FOR SYNTHESIS OF A CURABLE WAX | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110251334-A1 | SOLVENT-FREE PROCESS FOR SYNTHESIS OF A CURABLE WAX | XEROX CORPORATION (US) | 2011-10-13 | — | — | US | disclosed |
| US-4590301-A | USING PHENOL OR DIKETONE CYCLOHEXYL COMPOUNDS | BARNES-HIND, INC. (US) | 1986-05-20 | — | — | US | disclosed |
| EP-0179476-A1 | Polymerization inhibitors and polymerization-inhibited solutions of monomers | Barnes-Hind, Inc. (US) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110247521-A1 | SCALEABLE PROCESS FOR SYNTHESIS OF A CURABLE WAX | HACL2, USP14, USP16 | IDH1 4248/4885MAPT 1508/4885CA1 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.